NEW YORK, NY / ACCESSWIRE / November 5, 2022 / Pomerantz LLP is investigating claims on behalf of investors from Establishment Labs Holdings Inc. (“Establishment Labs” or the “Company”) (NASDAQ: ESTA). Those investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, extension 7980.
The investigation concerns whether Establishment Labs and certain of its officers and/or directors have engaged in securities fraud or other illegal business practices.
[Click here for information about joining the class action]
On October 19, 2022, Hindenburg Research (“Hindenburg”) released a report titled “Establishment Labs: A Financially Stretched Silicone Safety Charade.” The Hindenburg Report made, among other claims: “[t]The Establishment consultant, who was just hired to support its US launch, was sued by the SEC in 2018 for fraudulently lying and then destroying records that obscured regulatory and safety issues with breast implants:; “[d]Despite claims of superior safety, we have found that nearly all major safety studies touted by the company have conflicts of interest, many of which are under-disclosed or under-disclosed”; and “Australian and French authorities have raised concerns about the company’s data, with Australian regulators describing the company’s key safety data as “uncontrolled observational studies”.
As a result of this news, Establishment Labs stock price fell $5.22 per share, or 9.26%, to close at $51.13 per share on October 19…
